3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis
持续和分阶段释放抗生素和益生菌支架的 3D 生物打印用于治疗细菌性阴道病
基本信息
- 批准号:10580042
- 负责人:
- 金额:$ 76.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-25 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:3-Dimensional3D PrintAdherenceAdverse eventAffectAftercareAgeAlginatesAnaerobic BacteriaAntibiotic TherapyAntibioticsAntifungal AgentsAppearanceAtopobium vaginaeBackBacteriaBacterial VaginosisBiological AssayBiomedical EngineeringCalibrationCell LineCellsClinicalClinical ResearchClinical TrialsComplexComputer ModelsDataDevelopmentDevicesEpithelial CellsEpitheliumEquilibriumExperimental ModelsFemaleFormulationGardnerellaGardnerella vaginalisGelatinGoalsGrowthHIVHealthHistopathologyHumanIn VitroInfectionInfertilityInflammation MediatorsInvestigationKineticsLactobacillusLinkMeasurementMeasuresMedicineMetronidazoleMicrobeModelingMucous body substanceMusOralOutcomePelvic Inflammatory DiseasePhasePre-Clinical ModelPrevotellaPrintingProbioticsProcessProliferatingPropertyReapplicationRecordsRecurrenceRegimenRetreatmentSerumSexually Transmitted DiseasesSiliconesSymptomsSyndromeTestingTherapeuticTherapeutic AgentsTissuesTopical AntibioticTopical applicationTreatment EfficacyTreatment ProtocolsTreatment outcomeUterusVaginaWomanWorkadverse pregnancy outcomeagedbioprintingco-infectioncytotoxicitydelivery vehicledesigndysbiosisengineering designexperienceexperimental studyfabricationgut healthhigh riskimprovedimproved outcomein vitro Modelin vitro testingin vivomathematical modelmicrobialmicrobicidemouse modelmultidisciplinarynovelpathogenpre-clinicalpredictive modelingpreventprobiotic therapyprototypereduce symptomsreproductivereproductive tractscaffoldvaginal lactobacillivaginal microbiomevirtual
项目摘要
PROJECT SUMMARY
Bacterial vaginosis (BV) is a dysbiosis of the vaginal microbiome that affects ~29% of reproductive age women
and is linked with higher risks of adverse pregnancy outcomes, postsurgical infections, and sexually transmitted
infections. While lactobacilli typically dominate the healthy vagina, BV is characterized by low lactobacilli levels
and an overgrowth of diverse anaerobic bacteria, most often including Gardnerella and Prevotella. Current oral
or topical antibiotic treatments alleviate symptoms in 80% of women, at least temporarily. However, most women
will experience a recurrence of BV within one-year post-treatment. A recent clinical study showed that a vaginal
probiotic treatment regimen (with Lactobacillus crispatus), used following a vaginal course of antibiotics
(metronidazole), significantly improved long-term treatment efficacy. Unfortunately, current topically-applied
formulations require repeated administrations (once to twice daily), which can hinder female convenience and
adherence to treatment, particularly when undergoing multiple weeks of treatment (required to administer both
antibiotic and probiotics).
In this project we will use 3D printing and computational modeling, iteratively enabled by functional investigation
of prototype scaffolds in vitro and in vivo, to design long-acting products that sustain therapeutic delivery, while
enabling phased-delivery of antibiotics and probiotics to the female reproductive tract. Our team brings together
female reproductive tract-specific expertise in delivery vehicle design, computational modeling, and preclinical
BV models. The ultimate goal is to use 3D-bioprinting to incorporate different device compartments, which
sequentially release antibiotics that target anaerobic overgrowth, followed by live probiotics that restore balance
back in favor of vaginal lactobacilli. In Aim 1, we will design and characterize 3D-printed silicone scaffolds that
sustain antibiotic-only delivery. Aim 2 will design and evaluate 3D-printed silicone and gelatin alginate
composites that sequentially release antibiotics followed by probiotics, providing a “1-2 punch” strategy to kill BV
bacteria and provide a ‘healthy’ Lactobacillus alternative. Each aim will focus first on a materials-based
characterization of Met-containing silicone (1A) or Met-silicone probiotic-gelatin alginate composites (2A).
Measurements from in vitro release experiments will be used to develop and test computational models that
predict the delivery of antibiotic (1B) or dual agents (2B) in a “virtual female reproductive tract” and ultimately in
a mouse co-infection model. We will evaluate Met-silicone (1C) and Met-silicone probiotic-gelatin alginate
composites (2C) for cytotoxicity to the vaginal epithelium and ability to stimulate soluble proinflammatory
mediators and downstream histopathology. In our mouse model, we will measure levels of viable Gardnerella
and Prevotella recovered from vaginal and uterine tissues following treatment with blank or active agent-
containing 3D-printed scaffolds. If successful, this project will support the development of multipurpose platforms
to prevent and treat BV as well as other female reproductive tract applications.
项目摘要
细菌性阴道病(BV)是一种阴道微生物群失调,影响约29%的育龄妇女
并且与不良妊娠结局、术后感染和性传播的风险较高有关。
感染.虽然乳酸杆菌通常占主导地位的健康阴道,BV的特点是低乳酸杆菌水平
以及各种厌氧细菌的过度生长,最常见的包括加德纳菌和普雷沃菌。当前口服
或局部抗生素治疗缓解症状,在80%的妇女,至少暂时。然而,大多数女性
将在治疗后一年内发生BV复发。最近的一项临床研究表明,
益生菌治疗方案(使用卷曲乳杆菌),在抗生素阴道疗程后使用
(甲硝唑),显著提高长期治疗疗效。不幸的是,目前的主题应用
制剂需要重复给药(每天一至两次),这可能妨碍女性的便利性,
对治疗的依从性,特别是在接受多周治疗时(需要同时给予
抗生素和益生菌)。
在这个项目中,我们将使用3D打印和计算建模,通过功能调查迭代启用
原型支架在体外和体内,设计长效产品,维持治疗输送,而
从而能够将抗生素和益生菌分阶段递送到女性生殖道。我们的团队汇集了
女性生殖道特定的专业知识,在运载工具设计,计算建模,
BV模型。最终目标是使用3D生物打印来整合不同的设备隔间,
依次释放针对厌氧过度生长的抗生素,然后是恢复平衡的活益生菌
阴道乳酸杆菌的优势在目标1中,我们将设计和表征3D打印的硅胶支架,
维持只向南极运送。目标2将设计和评估3D打印硅胶和明胶藻酸盐
复合材料依次释放抗生素,然后释放益生菌,提供了杀死BV的“1-2拳”策略
细菌和提供一个'健康'乳酸菌的替代品。每个目标将首先侧重于一个基于材料的
含Met的硅氧烷(1A)或Met-硅氧烷益生菌-明胶藻酸盐复合物(2A)的表征。
体外释放实验的测量结果将用于开发和测试计算模型,
预测抗生素(1B)或双药剂(2B)在“虚拟女性生殖道”中的递送,并最终在
小鼠共感染模型。我们将评估Met-硅酮(1C)和Met-硅酮益生菌-藻酸明胶
复合物(2C)对阴道上皮细胞的细胞毒性和刺激可溶性促炎性细胞因子的能力
介质和下游组织病理学。在我们的小鼠模型中,我们将测量活加德纳菌的水平,
和在用空白或活性剂处理后从阴道和子宫组织中回收的普雷沃氏菌-
包含3D打印的支架。如果成功,该项目将支持多用途平台的开发
预防和治疗BV以及其他女性生殖道应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hermann Frieboes其他文献
Hermann Frieboes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hermann Frieboes', 18)}}的其他基金
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis
持续和分阶段释放抗生素和益生菌支架的 3D 生物打印用于治疗细菌性阴道病
- 批准号:
10420527 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis
了解宿主-微生物组-治疗三联体:设计替代阴道内给药平台治疗细菌性阴道病的意义
- 批准号:
10652467 - 财政年份:2019
- 资助金额:
$ 76.74万 - 项目类别:
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis
了解宿主-微生物组-治疗三联体:设计替代阴道内给药平台治疗细菌性阴道病的意义
- 批准号:
10443781 - 财政年份:2019
- 资助金额:
$ 76.74万 - 项目类别:
相似海外基金
Study on the use of 3D print models to improve understanding of geomorphic processes
研究使用 3D 打印模型来提高对地貌过程的理解
- 批准号:
22K13777 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
3D print-on-demand technology for personalised medicines at the point of care
用于护理点个性化药物的 3D 按需打印技术
- 批准号:
10045111 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Grant for R&D
Regenerative cooling optimisation in 3D-print rocket nozzles
3D 打印火箭喷嘴的再生冷却优化
- 批准号:
2749141 - 财政年份:2022
- 资助金额:
$ 76.74万 - 项目类别:
Studentship
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
- 批准号:
548945-2019 - 财政年份:2021
- 资助金额:
$ 76.74万 - 项目类别:
College - University Idea to Innovation Grants
Development of a New Powder Mix and Process Plan to 3D Print Ductile Iron Parts
开发用于 3D 打印球墨铸铁零件的新粉末混合物和工艺计划
- 批准号:
548945-2019 - 财政年份:2020
- 资助金额:
$ 76.74万 - 项目类别:
College - University Idea to Innovation Grants
Administrative Supplement for Equipment: 6-axis Positioner to Improve 3D Print Quality and Print Size
设备管理补充:用于提高 3D 打印质量和打印尺寸的 6 轴定位器
- 批准号:
10801667 - 财政年份:2019
- 资助金额:
$ 76.74万 - 项目类别:
SBIR Phase II: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第二阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
- 批准号:
1738138 - 财政年份:2017
- 资助金额:
$ 76.74万 - 项目类别:
Standard Grant
Development of "artificial muscle' ink for 3D print of microrobots
开发用于微型机器人3D打印的“人造肌肉”墨水
- 批准号:
17K18852 - 财政年份:2017
- 资助金额:
$ 76.74万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
I-Corps: Nanochon, a Commercial Venture to 3D Print Regenerative Implants for Joint Reconstruction
I-Corps:Nanochon,一家商业企业,致力于 3D 打印再生植入物进行关节重建
- 批准号:
1612567 - 财政年份:2016
- 资助金额:
$ 76.74万 - 项目类别:
Standard Grant
SBIR Phase I: Pellet based 3D print extrusion process for shoe manufacturing
SBIR 第一阶段:用于制鞋的基于颗粒的 3D 打印挤出工艺
- 批准号:
1621732 - 财政年份:2016
- 资助金额:
$ 76.74万 - 项目类别:
Standard Grant